SCHEMBL7833289

SCHEMBL7833289

Nc1ccc(S(=O)(=O)Nc2cc(Cl)nc(N3CCC3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
KDM4E B2RXH2 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
HTR6 P50406 5/20 0.48
PDE4A P27815 1/20 0.48
AGO2 Q9UKV8 1/20 0.48
MAPT P10636 4/20 0.47
ALDH1A1 P00352 4/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
APEX1 P27695 1/20 0.46
BLM P54132 1/20 0.46
ADRA1A P35348 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7823536 0.85 HTR6 (0.68) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL7823458 0.83 HTR6 (0.68) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL8416375 0.83 GAA (0.37) LMNAMAPTALDH1A1TDP1L3MBTL1
SCHEMBL7832160 0.82 L3MBTL1 (0.53) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL7838498 0.80 GFER (0.57) LMNAKDM4ENPSR1MAPTALDH1A1
SCHEMBL7833559 0.79 HTR6 (0.69) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL7837390 0.74 HTR6 (0.78) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL7824647 0.74 L3MBTL1 (0.67) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL7824442 0.74 HTR6 (0.67) LMNAKDM4ENPSR1HTR6PDE4A
SCHEMBL7833846 0.73 HTR6 (0.54) LMNAKDM4ENPSR1HTR6PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 EP disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 EP disclosed